From Name:
From Email:
To Name:
To Email:

Optional Message:

Modernizing vaccine surveillance systems to improve detection of rare or poorly defined adverse events

from The BMJ

Before vaccines are licensed, their efficacy has to be shown in clinical trials. The trials, however, are generally not powered to evaluate safety. Even phase III trials collect only limited safety data, mostly on common adverse events that occur shortly after vaccination such as local and systemic reactions related to the immunogenicity of the vaccine. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063